Global Health Segmentation Solutions Limited 13490546 false 2023-08-01 2024-07-31 2024-07-31 The principal activity of the company is is that of specialist medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true 13490546 2023-08-01 2024-07-31 13490546 2024-07-31 13490546 core:CurrentFinancialInstruments core:WithinOneYear 2024-07-31 13490546 bus:Micro-entities 2023-08-01 2024-07-31 13490546 bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 13490546 bus:FilletedAccounts 2023-08-01 2024-07-31 13490546 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 13490546 bus:RegisteredOffice 2023-08-01 2024-07-31 13490546 bus:Director1 2023-08-01 2024-07-31 13490546 bus:Director2 2023-08-01 2024-07-31 13490546 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 13490546 countries:AllCountries 2023-08-01 2024-07-31 13490546 2022-08-01 2023-07-31 13490546 2023-07-31 13490546 core:CurrentFinancialInstruments core:WithinOneYear 2023-07-31 iso4217:GBP xbrli:pure

Registration number: 13490546

Global Health Segmentation Solutions Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 July 2024

 

Global Health Segmentation Solutions Limited

Contents

Company Information

1

Directors' Report

2

Balance Sheet

3 to 4

Notes to the Unaudited Financial Statements

3

 

Global Health Segmentation Solutions Limited

Company Information

Directors

Dr Pankaj Garg

Mrs Svetlana Garg

Registered office

213 Derbyshire Lane
Norton Lees
Sheffield
South Yorkshire
S8 8SA

Accountants

Thorntons Accountants Limited
Chartered Certified Accountants
213 Derbyshire Lane
Norton Lees
Sheffield
South Yorkshire
S8 8SA

 

Global Health Segmentation Solutions Limited

Directors' Report for the Year Ended 31 July 2024

The directors present their report and the financial statements for the year ended 31 July 2024.

This report has been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and in accordance with FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime.

Directors of the company

The directors who held office during the year were as follows:

Dr Pankaj Garg

Mrs Svetlana Garg

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 13 March 2025 and signed on its behalf by:
 

.........................................
Dr Pankaj Garg
Director

 

Global Health Segmentation Solutions Limited

(Registration number: 13490546)
Balance Sheet as at 31 July 2024

2024
£

2023
£

Fixed assets

7,279

7,174

Current assets

184,014

83,052

Creditors: Amounts falling due within one year

(41,528)

(28,467)

Net current assets

142,486

54,585

Total assets less current liabilities

149,765

61,759

Accruals and deferred income

(1,260)

(1,200)

 

148,505

60,559

Capital and reserves

148,505

60,559

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
213 Derbyshire Lane
Norton Lees
Sheffield
South Yorkshire
S8 8SA

These financial statements were authorised for issue by the Board on 13 March 2025.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

For the financial year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

Global Health Segmentation Solutions Limited

(Registration number: 13490546)
Balance Sheet as at 31 July 2024

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 13 March 2025 and signed on its behalf by:
 

.........................................
Dr Pankaj Garg
Director